Ebola virus disease and the veterinary perspective

doi:10.1186/s12941-015-0089-x

Review

. 2015 May 28:14:30.

doi: 10.1186/s12941-015-0089-x.

Ebola virus disease and the veterinary perspective

Semra Gumusova¹, Mustafa Sunbul², Hakan Leblebicioglu³

Affiliations

¹ Department of Virology, School of Veterinary Medicine, Ondokuz Mayis University, Samsun, Turkey. semragumusova@hotmail.com.
² Department of Infectious Diseases and Clinical Microbiology, Medical School, Ondokuz Mayis University, Samsun, Turkey. msunbul@omu.edu.tr.
³ Department of Infectious Diseases and Clinical Microbiology, Medical School, Ondokuz Mayis University, Samsun, Turkey. hakanomu@yahoo.com.

PMID: 26018030
PMCID: PMC4450609
DOI: 10.1186/s12941-015-0089-x

Review

Ebola virus disease and the veterinary perspective

Semra Gumusova et al. Ann Clin Microbiol Antimicrob. 2015.

. 2015 May 28:14:30.

doi: 10.1186/s12941-015-0089-x.

Authors

Semra Gumusova¹, Mustafa Sunbul², Hakan Leblebicioglu³

Affiliations

¹ Department of Virology, School of Veterinary Medicine, Ondokuz Mayis University, Samsun, Turkey. semragumusova@hotmail.com.
² Department of Infectious Diseases and Clinical Microbiology, Medical School, Ondokuz Mayis University, Samsun, Turkey. msunbul@omu.edu.tr.
³ Department of Infectious Diseases and Clinical Microbiology, Medical School, Ondokuz Mayis University, Samsun, Turkey. hakanomu@yahoo.com.

PMID: 26018030
PMCID: PMC4450609
DOI: 10.1186/s12941-015-0089-x

Abstract

Ebola virus disease (EVD) is a potentially fatal haemorrhagic disease of humans. The last and most serious outbreak of Ebola virus (EBOV) started in December 2013 in West Africa and also affected other continents. Animals such as fruit bats and non-human primates are potential sources of EBOV. This review highlights the clinical features of EVD in humans and animals and addresses the public health implications of EVD outbreaks from the veterinary perspective.

PubMed Disclaimer

Cited by

Contrasting academic and lay press print coverage of the 2013-2016 Ebola Virus Disease outbreak.
Kieh MD, Cho EM, Myles IA. Kieh MD, et al. PLoS One. 2017 Jun 22;12(6):e0179356. doi: 10.1371/journal.pone.0179356. eCollection 2017. PLoS One. 2017. PMID: 28640889 Free PMC article.
Environmental Risk Assessment for rVSVΔG-ZEBOV-GP, a Genetically Modified Live Vaccine for Ebola Virus Disease.
Tell JG, Coller BG, Dubey SA, Jenal U, Lapps W, Wang L, Wolf J. Tell JG, et al. Vaccines (Basel). 2020 Dec 19;8(4):779. doi: 10.3390/vaccines8040779. Vaccines (Basel). 2020. PMID: 33352786 Free PMC article. Review.
Identification of promising anti-EBOV inhibitors: de novo drug design, molecular docking and molecular dynamics studies.
Mohamed EAR, Abdelwahab SF, Alqaisi AM, Nasr AMS, Hassan HA. Mohamed EAR, et al. R Soc Open Sci. 2022 Sep 28;9(9):220369. doi: 10.1098/rsos.220369. eCollection 2022 Sep. R Soc Open Sci. 2022. PMID: 36177201 Free PMC article.
Animal Models of Ebolavirus Infection.
St Claire MC, Ragland DR, Bollinger L, Jahrling PB. St Claire MC, et al. Comp Med. 2017 Jun 1;67(3):253-262. Comp Med. 2017. PMID: 28662754 Free PMC article. Review.
Vaccine Preventable Zoonotic Diseases: Challenges and Opportunities for Public Health Progress.
Carpenter A, Waltenburg MA, Hall A, Kile J, Killerby M, Knust B, Negron M, Nichols M, Wallace RM, Behravesh CB, McQuiston JH, The Vaccine Preventable Zoonotic Disease Working Group. Carpenter A, et al. Vaccines (Basel). 2022 Jun 22;10(7):993. doi: 10.3390/vaccines10070993. Vaccines (Basel). 2022. PMID: 35891157 Free PMC article. Review.

References

1. Ebola haemorrhagic fever in Zaire, 1976. Bull World Health Organ 1978, 56(2):271–293. - PMC - PubMed
1. Allaranga Y, Kone ML, Formenty P, Libama F, Boumandouki P, Woodfill CJ, Sow I, Duale S, Alemu W, Yada A. Lessons learned during active epidemiological surveillance of Ebola and Marburg viral hemorrhagic fever epidemics in Africa. East Afr J Public Health. 2010;7(1):30–6. - PubMed
1. Ebola Situation Report - 6 May 2015 [http://apps.who.int/ebola/en/current-situation/ebola-situation-report-6-...]
1. Beeching NJ, Fenech M, Houlihan CF. Ebola virus disease. BMJ. 2014;349:g7348. doi: 10.1136/bmj.g7348. - DOI - PMC - PubMed
1. Bausch DG, Towner JS, Dowell SF, Kaducu F, Lukwiya M, Sanchez A, Nichol ST, Ksiazek TG, Rollin PE. Assessment of the risk of Ebola virus transmission from bodily fluids and fomites. J Infect Dis. 2007;196(Suppl 2):S142–7. doi: 10.1086/520545. - DOI - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information

[1] Ebola haemorrhagic fever in Zaire, 1976. Bull World Health Organ 1978, 56(2):271–293. - PMC - PubMed

[2] Ebola haemorrhagic fever in Zaire, 1976. Bull World Health Organ 1978, 56(2):271–293. - PMC - PubMed

[3] Allaranga Y, Kone ML, Formenty P, Libama F, Boumandouki P, Woodfill CJ, Sow I, Duale S, Alemu W, Yada A. Lessons learned during active epidemiological surveillance of Ebola and Marburg viral hemorrhagic fever epidemics in Africa. East Afr J Public Health. 2010;7(1):30–6. - PubMed

[4] Allaranga Y, Kone ML, Formenty P, Libama F, Boumandouki P, Woodfill CJ, Sow I, Duale S, Alemu W, Yada A. Lessons learned during active epidemiological surveillance of Ebola and Marburg viral hemorrhagic fever epidemics in Africa. East Afr J Public Health. 2010;7(1):30–6. - PubMed

[5] Ebola Situation Report - 6 May 2015 [http://apps.who.int/ebola/en/current-situation/ebola-situation-report-6-...]

[6] Ebola Situation Report - 6 May 2015 [http://apps.who.int/ebola/en/current-situation/ebola-situation-report-6-...]

[7] Beeching NJ, Fenech M, Houlihan CF. Ebola virus disease. BMJ. 2014;349:g7348. doi: 10.1136/bmj.g7348. - DOI - PMC - PubMed

[8] Beeching NJ, Fenech M, Houlihan CF. Ebola virus disease. BMJ. 2014;349:g7348. doi: 10.1136/bmj.g7348. - DOI - PMC - PubMed

[9] Bausch DG, Towner JS, Dowell SF, Kaducu F, Lukwiya M, Sanchez A, Nichol ST, Ksiazek TG, Rollin PE. Assessment of the risk of Ebola virus transmission from bodily fluids and fomites. J Infect Dis. 2007;196(Suppl 2):S142–7. doi: 10.1086/520545. - DOI - PubMed

[10] Bausch DG, Towner JS, Dowell SF, Kaducu F, Lukwiya M, Sanchez A, Nichol ST, Ksiazek TG, Rollin PE. Assessment of the risk of Ebola virus transmission from bodily fluids and fomites. J Infect Dis. 2007;196(Suppl 2):S142–7. doi: 10.1086/520545. - DOI - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Ebola virus disease and the veterinary perspective

Affiliations

Ebola virus disease and the veterinary perspective

Authors

Affiliations

Abstract

Similar articles

Cited by

References

Publication types

MeSH terms

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Abstract

Similar articles

Cited by

References

Publication types

MeSH terms

Related information

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical